Literature DB >> 10590090

Extended analysis of the in vitro tropism of porcine endogenous retrovirus.

C A Wilson1, S Wong, M VanBrocklin, M J Federspiel.   

Abstract

We previously reported that mitogenic activation of porcine peripheral blood mononuclear cells resulted in production of porcine endogenous retrovirus(es) (PERV[s]) capable of productively infecting human cells (C. Wilson et al., J. Virol. 72:3082-3087, 1998). We now extend that analysis to show that additional passage of isolated virus, named here PERV-NIH, through a human cell line yielded a viral population with a higher titer of infectious virus on human cells than the initial isolate. We show that in a single additional passage on a human cell line, the increase in infectivity for human cells is accounted for by selection against variants carrying pig-tropic envelope sequences (PERV-C) as well as by enrichment for replication-competent genomes. Sequence analysis of the envelope cDNA present in virions demonstrated that the envelope sequence of PERV-NIH is related to but distinct from previously reported PERV envelopes. The in vitro host range of PERV was studied in human primary cells and cell lines, as well as in cell lines from nonhuman primate and other species. This analysis reveals three patterns of susceptibility to infection among these host cells: (i) cells are resistant to infection in our assay; (ii) cells are infected by virus, as viral RNA is detected in the supernatant by reverse transcription-PCR, but the cells are not permissive to productive replication and spread; and (iii) cells are permissive to low-level productive replication. Certain cell lines were permissive for efficient productive infection and spread. These results may prove useful in designing appropriate animal models to assess the in vivo infectivity properties of PERV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590090      PMCID: PMC111512          DOI: 10.1128/jvi.74.1.49-56.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).

Authors:  J Yodoi; K Teshigawara; T Nikaido; K Fukui; T Noma; T Honjo; M Takigawa; M Sasaki; N Minato; M Tsudo
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

2.  C-type virus particles in pig kidney cell lines.

Authors:  J A Armstrong; J S Porterfield; A T De Madrid
Journal:  J Gen Virol       Date:  1971-02       Impact factor: 3.891

3.  Phenotypic mixing between avian and mammalian RNA tumor viruses: I. Envelope pseudotypes of Rous sarcoma virus.

Authors:  R A Weiss; A L Wong
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

4.  Biologic and immunologic properties of porcine type C viruses.

Authors:  M M Lieber; C J Sherr; R E Benveniste; G J Todaro
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

5.  Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboons.

Authors:  U Martin; G Steinhoff; V Kiessig; M Chikobava; M Anssar; T Morschheuser; B Lapin; A Haverich
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

6.  Viral and cellular factors governing hamster cell infection by murine and gibbon ape leukemia viruses.

Authors:  C A Wilson; M V Eiden
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Suppression of the hypomethylated Moloney leukemia virus genome in undifferentiated teratocarcinoma cells and inefficiency of transformation by a bacterial gene under control of the long terminal repeat.

Authors:  O Niwa
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

8.  Factors affecting retroviral vector function and structural integrity.

Authors:  J R McLachlin; N Mittereder; M B Daucher; M Kadan; M A Eglitis
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

9.  Oncogenicity of gibbon type-C myelogenous leukemia virus.

Authors:  T G Kawakami; G V Kollias; C Holmberg
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

10.  Role of proliferation in LAK cell development.

Authors:  F J Ramsdell; H Shau; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more
  61 in total

1.  Comparison of replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from pig and human cells.

Authors:  U Krach; N Fischer; F Czauderna; R R Tönjes
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A.

Authors:  Peter M Mazari; Takele Argaw; Leonardo Valdivieso; Xia Zhang; Katherine T Marcucci; Daniel R Salomon; Carolyn A Wilson; Monica J Roth
Journal:  Virology       Date:  2012-03-08       Impact factor: 3.616

3.  Retroviral restriction factors and infectious risk in xenotransplantation.

Authors:  Y Meije; R R Tönjes; J A Fishman
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 4.  The origin of porcine endogenous retroviruses (PERVs).

Authors:  Joachim Denner
Journal:  Arch Virol       Date:  2021-02-06       Impact factor: 2.574

5.  Determinants of high titer in recombinant porcine endogenous retroviruses.

Authors:  Ian Harrison; Yasuhiro Takeuchi; Birke Bartosch; Jonathan P Stoye
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Reliable classification and recombination analysis of porcine endogenous retroviruses.

Authors:  Nikolai Klymiuk; Bernhard Aigner
Journal:  Virus Genes       Date:  2005-05       Impact factor: 2.332

7.  The number of a U3 repeat box acting as an enhancer in long terminal repeats of polytropic replication-competent porcine endogenous retroviruses dynamically fluctuates during serial virus passages in human cells.

Authors:  G Scheef; N Fischer; U Krach; R R Tönjes
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Identification of Porcine Endogenous Retrovirus (PERV) packaging sequence and development of PERV packaging viral vector system.

Authors:  Jiwon Choi; Hoon-mi Kim; Jong Kwang Yoon; Yeondong Cho; Hee-Jung Lee; Kang Chang Kim; Chang-Kyu Kim; Gye-Woong Kim; Young Bong Kim
Journal:  J Microbiol       Date:  2015-05-03       Impact factor: 3.422

9.  Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection.

Authors:  Y Martina; K T Marcucci; S Cherqui; A Szabo; T Drysdale; U Srinivisan; C A Wilson; C Patience; D R Salomon
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha.

Authors:  Andrew Wood; Benjamin L J Webb; Birke Bartosch; Torsten Schaller; Yasuhiro Takeuchi; Greg J Towers
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.